CBOE Global Markets: Attractive Valuation With Significant Growth Runway (Rating Upgrade)

CBOE Global Markets was upgraded from Hold to Buy after Q3 adjusted EPS rose 36% year over year and net revenue increased 17.5%, driven by options growth. The stock trades at an approximately 25% discount to its five-year average P/E, with projected future returns just above 20%.

Analysis

The key question is whether the earnings strength reflects durable share gains and product mix or a volatility-driven volume spike. If the latter, annualizing the quarter risks overstating normalized earnings: a volatility normalization could hit both revenue expectations and the multiple, making the historical P/E discount less informative. Conversely, persistent options activity and continued product adoption could support a higher earnings base; that would make the discount a potential rerating opportunity rather than a simple mean-reversion trade.

Over the next 1–3 months, monitor options activity and management’s forward commentary for evidence that momentum extends beyond one quarter. Over 6–18 months, the structural test is whether Cboe can sustain growth through calmer markets and defend its position against competing derivatives venues, including CME Group and Intercontinental Exchange. The upgrade itself is not proof that the discount will close, and the supplied information does not establish current positioning, consensus expectations, or the source of the valuation gap.

The contrarian risk is that investors are treating unusually favorable activity as recurring earnings while the market is correctly discounting cyclicality. A sustained drop in options activity, weaker forward guidance, or earnings growth falling short of the implied run rate would falsify the rerating thesis. No price target or precise risk/reward can be responsibly derived from the information provided.

Key Decisions for Investors

• Consider a staged long in CBOE rather than chasing the upgrade: add only if follow-through in options activity and forward guidance supports durable earnings, and define risk against a break below the post-earnings trading range once current price data are checked.
• Use the next 1–3 months to verify the quality of growth: track options volume and mix, realized market volatility, and management commentary on recurring demand. If activity fades without offsetting product or share gains, reduce exposure rather than relying on the historical P/E discount.
• Treat the valuation gap as a catalyst-dependent thesis, not a standalone buy signal. Compare Cboe’s normalized earnings outlook and valuation with CME Group and Intercontinental Exchange before considering a relative-value position.
• No options trade is indicated on the supplied evidence; current implied volatility, share-price reaction, positioning, and the drivers of the P/E discount are missing.